Open AccessCOVID-19 dengan Komorbid Tuberkulosis Paru dan Diabetes Melitus
Author(s) -
Muthia Faurin,
Fauzar Fauzar,
Roza Kurniati,
Alexander Kam,
Eva Decroli
Publication year - 2021
Publication title -
jurnal ilmu kesehatan indonesia
Language(s) - English
Resource type - Journals
ISSN - 2722-4848
DOI - 10.25077/jikesi.v1i3.466
Subject(s) - medicine , diabetes mellitus , pulmonary tuberculosis , covid-19 , tuberculosis , pharmacotherapy , intensive care medicine , pediatrics , disease , pathology , infectious disease (medical specialty) , endocrinology
A 61-year-old man was admitted a confirmed COVID-19 with comorbid pulmonary tuberculosis and type 2 diabetes mellitus. The patient was given favipiravir therapy, category 1 of antituberculosis drug, and insulin therapy. The patient responded well to therapy with improved clinical and laboratory indicators.
Key words: COVID-19, pulmonary tuberculosis, diabetes mellitus